FDA loses case over folic acid claim

- Last updated on GMT

Related tags: Folic acid, Food and drug administration, Fda

The US Food and Drug Administration (FDA) is reported to have lost its case in
attempting to deny a folic...

The US Food and Drug Administration (FDA)​ is reported to have lost its case in attempting to deny a folic acid claim proposed by the plaintiff in thePearson versus Shalala dietary supplements labelling case. The US District Court for the District of Columbia found that the FDA failed to comply with the constitutional guidelines outlined in Pearson and either ignored or misunderstood highly relevant portions of the Pearson decision. The claim relates is that 0.8mg of folic acid in a dietary supplement is more effective in reducing the risk of neural tube defects than a lower amount infoods in common form. Source: Food Chemical News

Related topics: Policy

Follow us

Featured Events

View more

Products

View more

Webinars